The Transgenic Mouse Shared Resource is a fully Cancer Center-managed facility. The generation and use of transgenic and gene-targeted mice is an essential technology for basic cancer research. Since its establishment in 1995 the Transgenic Mouse Shared Resource has served to make transgenic technologies accessible to all Cancer Center members, which has had a major impact on the quality and quantity of cancer research using genetically modified mouse models. The resource has served over 80 different investigators over the past three years, and has generated hundreds of new strains of transgenic and gene-targeted mice. The services provided by the Transgenic Mouse Shared Resource are: ? Production of transgenic mice by pronuclear DMA microinjection and embryo transfer; ? Production of chimeric mice by blastocyst injection of genetically modified ES cells and embryo transfer, which is part of the procedure of producing knockout or knockin mice;and ? Gene targeting, which involves the electroporation of a targeting vector into pluripotent mouse embryonic stem (ES) cells and the selection of gene-targeted clones; ? Education of investigators and advice on vector and experimental design for experiments using transgenic and knockout mice. The facility maintains a library of vectors and genes that are generally useful for the construction of transgenes and targeting vectors. In the future, to supplement these now standard transgenic methods, we plan to establish a service that will use """"""""BAG recombineering"""""""" to efficiently produce large-insert gene targeting vectors and transgenes. Beyond these specific fee-based services, the Resource provides free advice and consultation on all aspects of the design, generation, breeding and analysis of genetically modified mouse models. The Director (Dr. Frank Costantini), Co-Director (Dr. Thomas Ludwig) and Manager (Dr. Chyuan-Sheng Lin) of the facility collectively have many decades of experience in numerous aspects of mouse genetics, transgenic mo'use technology, and the use of mouse models in cancer research, and their expertise has contributed greatly to the excellence of transgenic mouse research at Columbia. During the last period of the CCSG, 51% of the investigators using the facility were Cancer Center members with peer-reviewed funding, with those members representing from 53% to 78% of the usage of the 3 available services. The proposed total operating budget of the facility is $531,018 for the Transgenic Mouse Shared Resource, of which we are requesting $183,948 from the CGSG. In addition, mouse cage costs managed by the Institute for Comparative Medicine are $324,111, of which we are requesting $135,771 from the CCSG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013696-39
Application #
8375779
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
39
Fiscal Year
2012
Total Cost
$406,666
Indirect Cost
$154,164
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Billing, David; Horiguchi, Michiko; Wu-Baer, Foon et al. (2018) The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection. Mol Cell 72:127-139.e8
Connors, Thomas J; Baird, J Scott; Yopes, Margot C et al. (2018) Developmental Regulation of Effector and Resident Memory T Cell Generation during Pediatric Viral Respiratory Tract Infection. J Immunol 201:432-439
Brescia, Paola; Schneider, Christof; Holmes, Antony B et al. (2018) MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis. Cancer Cell 34:453-465.e9
Wu, Hui-Chen; Do, Catherine; Andrulis, Irene L et al. (2018) Breast cancer family history and allele-specific DNA methylation in the legacy girls study. Epigenetics 13:240-250
Sitko, Austen A; Kuwajima, Takaaki; Mason, Carol A (2018) Eye-specific segregation and differential fasciculation of developing retinal ganglion cell axons in the mouse visual pathway. J Comp Neurol 526:1077-1096
Tzoneva, Gannie; Dieck, Chelsea L; Oshima, Koichi et al. (2018) Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia. Nature 553:511-514
Wang, Gang; Biswas, Anup K; Ma, Wanchao et al. (2018) Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle. Nat Med 24:770-781
Chen, Yen-Hua; Kratchmarov, Radomir; Lin, Wen-Hsuan W et al. (2018) Asymmetric PI3K Activity in Lymphocytes Organized by a PI3K-Mediated Polarity Pathway. Cell Rep 22:860-868
Cho, Galaxy Y; Schaefer, Kellie A; Bassuk, Alexander G et al. (2018) CRISPR GENOME SURGERY IN THE RETINA IN LIGHT OF OFF-TARGETING. Retina 38:1443-1455
Zyablitskaya, Mariya; Munteanu, E Laura; Nagasaki, Takayuki et al. (2018) Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking (TXL) for Myopia. J Vis Exp :

Showing the most recent 10 out of 331 publications